A
Angelo Corti
Researcher at Vita-Salute San Raffaele University
Publications - 265
Citations - 12541
Angelo Corti is an academic researcher from Vita-Salute San Raffaele University. The author has contributed to research in topics: Chromogranin A & Tumor necrosis factor alpha. The author has an hindex of 58, co-authored 252 publications receiving 11817 citations. Previous affiliations of Angelo Corti include Istituto Italiano di Tecnologia & European Institute of Oncology.
Papers
More filters
Journal ArticleDOI
Tumor Necrosis Factor Soluble Receptors in Patients With Various Degrees of Congestive Heart Failure
Roberto Ferrari,Tiziana Bachetti,Roberta Confortini,Cristina Opasich,Oreste Febo,Angelo Corti,Giovanni Cassani,Odoardo Visioli +7 more
TL;DR: Measurement of sTNF-Rs, in addition to antigenic and bioactive TNF-alpha, is essential for evaluation of the activation of this cytokine in CHF and might inhibit the in vitro cytotoxicity of T NF-alpha.
Journal ArticleDOI
The receptor-binding sequence of urokinase. A biological function for the growth-factor module of proteases.
Ettore Appella,Elizabeth A. Robinson,Ullrich Sj,M P Stoppelli,Angelo Corti,Giovanni Cassani,Francesco Blasi +6 more
TL;DR: The area within ATF responsible for specific receptor binding has now been identified by the ability of different synthetic peptides corresponding to different regions of the amino terminus of uPA to inhibit receptor binding of 125I-labeled ATF.
Journal ArticleDOI
Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes.
M P Stoppelli,Angelo Corti,Adolfo Soffientini,Giovanni Cassani,Francesco Blasi,Richard K. Assoian +5 more
TL;DR: An important role for urokinase in monocyte/macrophage biology is suggested: the native enzyme binds to the cells with the amino-terminal domain; the catalytic, carboxyl- terminal domain remains exposed on the cell surface to stimulate localized proteolysis and facilitate cell migration.
Journal ArticleDOI
Enhancement of tumor necrosis factor alpha antitumor immunotherapeutic properties by targeted delivery to aminopeptidase N (CD13).
TL;DR: Results suggest that targeted delivery of TNF to CD13 may enhance its immunotherapeutic properties, and reveal the potential of tumor homing peptides to generate a new class of recombinant cytokines that compared to immunocytokines have a simpler structure, could be easier to produce and are potentially less immunogenic.
Journal ArticleDOI
Autocrine saturation of pro-urokinase receptors on human A431 cells.
M. Patrizia Stoppelli,Carlo Tacchetti,M. Vittoria Cubellis,Angelo Corti,Vincent J. Hearings,Giovanni Cassani,Ettore Appella,Francesco Blasi +7 more
TL;DR: It is proposed that the synthesis of uPA and uPA receptor by the same cell may provide a pathway for the activation of the metastatic potential of malignant cells.